| Balance Sheets | 2025-09-30 | 2025-06-30 | ||
|---|---|---|---|---|
| Cash | 2,321,078 | 2,924,395 | ||
| Prepaid expenses | 1,419,162 | 1,581,074 | ||
| Total current assets | 3,740,240 | 4,505,469 | ||
| Total assets | 3,740,240 | 4,505,469 | ||
| Accounts payable | 77,243 | 172,698 | ||
| Accrued expenses | 55,859 | 48,495 | ||
| Notes payable, current | 214,309 | 371,661 | ||
| Total current liabilities | 347,411 | 592,854 | ||
| Derivative financial instruments-warrants | 68,397 | 115,677 | ||
| Total liabilities | 415,808 | 708,531 | ||
| Convertible preferred stock-Series APreferred Stock | 855,808 | 855,808 | ||
| Convertible preferred stock-Series CPreferred Stock | 839,320 | 839,320 | ||
| Common stock0.0001 par value per share 120,000,000 shares authorized, 11,620,317 and 139,168 shares issued and outstanding at september 30, 2025 and december 31, 2024, respectively | 1,162 | 1,162 | ||
| Additional paid-in capital | 247,060,568 | 247,060,568 | ||
| Accumulated other comprehensive income | 8,345 | 8,345 | ||
| Accumulated deficit | -245,440,771 | -244,968,265 | ||
| Total stockholders equity | 3,324,432 | 3,796,938 | ||
| Total liabilities and stockholders equity | 3,740,240 | 4,505,469 | ||
Hepion Pharmaceuticals, Inc. (HEPA)
Hepion Pharmaceuticals, Inc. (HEPA)